Özgür Kara

Özgür Kara

Auto-generated profile, based on publicly available information

Özgür Kara

Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Education Hospital, 06200, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2016 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
SKSuleyman Karaman
Suleyman Karaman
BOBerna Ozkan
Berna Ozkan
MGMustafa Gok
Mustafa Gok
IKIsık Karakaya
Isık Karakaya
OKOzgur Kara
Ozgur Kara
LALevent Altintas
Levent Altintas

10 December 2024 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
TTTülay Tiftik
Tülay Tiftik
MKMurat Kara
Murat Kara
CMCevriye Mülkoğlu
Cevriye Mülkoğlu
IÇİrEm Çiftçi
İrEm Çiftçi
ÖÇÖmer Faruk Çelik
Ömer Faruk Çelik
LÖLevent Özçakar
Levent Özçakar

1 January 2022 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
ZÜZekeri̇yA Ülger
Zekeri̇yA Ülger
GAGözde Şengül Ayçiçek
Gözde Şengül Ayçiçek
ÖKÖzgür Kara
Özgür Kara
MKMurat Kara
Murat Kara
Background/aim: Sarcopenia and dementia are growing concerns among older adults that muscle and brain atrophy may cooccur. We aimed to compare the age-related loss of muscle mass by using ultrasound (US), and skeletal muscle mass index (SMI) by bioelectrical impedance analysis in older adults with and without dementia. Materials and methods: A total of 221 older adults aged ≥65 years were included in the study. The diagnosis of sarcopenia was established if low muscle mass according to either SMI or sonographic gastrocnemius (GC) muscle thickness was combined with low grip strength. The diagnosis of dementia was based on the National Institute of Aging and Alzheimer's Association criteria and the major neurocognitive disorder definition in the Diagnostic and Statistical Manual of Mental Disorders-V. Muscle strength was measured by hand dynamometer and physical performance was assessed by 4-meter usual gait speed. Results: There were similar/moderate correlation coefficients between GC muscle thickness and SMI with functional parameters (all p < 0.01). Forty-six patients (20.8%) had dementia, and 21 (45.7%) of them had sarcopenia diagnosed by GC thickness (p < 0.001). Age was older but weight, body mass index, and all sarcopenia-related parameters were lower in dementia patients (all p < 0.01). When clinical variables were taken into binary logistic regression analyses, age [OR = 1.095 (95% CI: 1.028-1.167)], weight [OR = 0.918 (95% CI: 0.887-0.950)], and presence of dementia [OR = 5.109 (95% CI: 2.002-13.033)] were independently associated with sarcopenia diagnosed with GC muscle thickness (all p < 0.05). Conclusion: This study showed that sarcopenia is highly prevalent in older adults with dementia (45.7%) than without dementia (11.4%). Amongst different factors, increased age, having low body weight, and the presence of dementia independently increased the risk of sarcopenia diagnosed by GC muscle thickness (but not diagnosed by SMI) in older adults. Thus, we can evaluate easily and successfully the loss of (regional) muscle mass in dementia patients by using US in outpatient clinics.

1 April 2019 in European Journal of Geriatrics and Gerontology
Verified
Journal Article
Closed access
RDRana Tuna Doğrul
Rana Tuna Doğrul
HVHacer Dogan Varan
Hacer Dogan Varan
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
MKMustafa Kemal Kılıç
Mustafa Kemal Kılıç
GAGunes Arik
Gunes Arik
BDBurcu Balam Dogu
Burcu Balam Dogu

29 January 2021 in Marmara Medical Journal
Verified
Journal Article
Closed access
PDF file
GAGözde Şengül Ayçiçek
Gözde Şengül Ayçiçek
GAGunes Arik
Gunes Arik
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
FSFatih Sumer
Fatih Sumer
OPOmer Osman Pala
Omer Osman Pala
ZUZekeriya Ulger
Zekeriya Ulger
Objective: Polypharmacy, an important geriatric syndrome, has been shown to be an independent risk factor for falling. However, the data about effects of polypharmacy on balance is lacking. We aimed to evaluate the effects of polypharmacy and inappropriate drug use on balance in older adults. Patients and Methods: Fifty-one patients using ≥ 5 drugs and 50 patients using < 5 drugs were included in the study. Inappropriate drug usage of the patients was evaluated by Beers criteria. Postural stability and risk of falling was investigated by using Biosway Portable Balance System (BPBS). Activities and functional status of the patients were assessed by using Short Physical Performance Battery (SPPB) and Activities Specific Balance Confidence Scale (ABC). All patients underwent comprehensive geriatric assessment. Results: Age, gender, hand grip strength, SPPB scores of the patients were similar between polypharmacy and control groups (all had p>0.05). ABC score was higher in polypharmacy group than control (p<0.01). Overall, anterior-posterior, medial-lateral stability index and eyes closed firm surface scores detected in BPBS were higher, indicating worse stability in the polypharmacy group than control (p<0.05). Limit of stability score was lower in the polypharmacy group than control (p=0.03). Rates of polypharmacy and inappropriate drug usage were higher in patients with a history of falling than without (p<0.01, p<0.01, respectively). In multivariate analysis model, polypharmacy was found to be an independently correlated parameter for impaired balance (OR 24.31; 95%CI 3.05- 193.91; p<0.01). Conclusion: This study has demonstrated that polypharmacy might be a related factor for impaired balance. Struggling with polypharmacy should be one of the most important part of comprehensive geriatric assessment.

21 October 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Closed access
RDRana Tuna Doğrul
Rana Tuna Doğrul
HVHacer Dogan Varan
Hacer Dogan Varan
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
MKMustafa Kemal Kılıç
Mustafa Kemal Kılıç
ÖKÖzgür Kara
Özgür Kara
BDBurcu Balam Dogu
Burcu Balam Dogu
Background/aim: Physical frailty is thought to be related with a decline in cognitive function, mood, and social activities, especially in patients with depression and dementia. It is not clear whether or not physical frailty is associated with an impairment in cognitive function and mood in patients without dementia and depression. In this study, we evaluated the association of physical frailty with cognitive function and mood in geriatric patients without dementia and depression. Material and methods: In this study, 612 patients aged 65 years and over were evaluated. Physical frailty was assessed by using Fried criteria. Furthermore, comprehensive geriatric assessment was performed to each patient. Results: Median age of the patients was 72 years (min-max: 65-93), 58% were female, and 6.5% were frail. Clock drawing (p < 0.001), MMSE (p < 0.001), and Yesevage geriatric depression scale (p: 0.010) test results were worse in frail patients compared to pre-frail and robust ones. Age (p: 0.009), being university graduate (p: 0.031), three words recall test (p: 0.014), activities of daily living (ADL) (p: 0.006), instrumental activities of daily living (IADL) (p < 0.001), and MNA-SF (p: 0.001) scores were determined to be independent related factors of frailty. Conclusion: We have demonstrated that cognitive function and mood might be associated with physical frailty in patients without dementia and depression.